UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030607
Receipt number R000034784
Scientific Title A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder
Date of disclosure of the study information 2019/02/17
Last modified on 2023/07/03 11:27:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Acronym

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Scientific Title

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Scientific Title:Acronym

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Region

Japan


Condition

Condition

None

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the anti-obesity effect of intakeof capsules containing noni fruit powder for 4 weeks

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Body weight, BMI

Key secondary outcomes

Waist circumference, Visceral fat area, Total fat percentage, Total fat area


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of capsules containing noni fruit powder for 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

55 years-old >

Gender

Male and Female

Key inclusion criteria

1) Subject whose age of 20 years or more and less than 55 years at informed consent
2) Subject whose BMI is 25 kg/m2 or more and less than 30 kg/m2
3) Subject who weighs less than 88 kg
4) Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Key exclusion criteria

1) Subject who has a mental disease such as depression, schizophrenia, epilepsy or bulimia nervosa
2) Subject who has allergic disease, cardiovascular, respiratory, thyroid gland malfunction, diabetes, heart disease, brain disease, gout or sleep disorder
3) Subject who takes regularly medicinal drugs or pharmaceuticals having an effect on the weight
4) Subject who has the possibility of developing allergic symptoms by the test food (noni allergy)
5) Subject who has a snacking habit
6) Female subject who is pregnant or may be pregnant
7) Female subject who is in lactating
8) Subject who has blood sample of 200 ml or more within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood)
9) Subject who participated in other clinical trials within the past 4 months or currently participates in other clinical trials or plans to participate in other clinical trials during the examination period
10) Subject deemed unsuitable by the investigator

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiro Fukuda

Organization

Fukuda Clinic

Division name

Director

Zip code


Address

Shin-Osaka Brick Building 2F, 1-6-1, Miyahara, Yodogawa-ku, Osaka

TEL

06-6398-0203

Email

fukuda@drmog.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohiro Sugino

Organization

Soiken Inc.

Division name

R&D Division

Zip code


Address

Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka

TEL

06-6871-8888

Homepage URL


Email

sugino@soiken.com


Sponsor or person

Institute

Soiken Inc.

Institute

Department

Personal name



Funding Source

Organization

ASKA Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 16 Day

Date of IRB

2017 Year 09 Month 16 Day

Anticipated trial start date

2018 Year 01 Month 06 Day

Last follow-up date

2018 Year 02 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 28 Day

Last modified on

2023 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034784


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name